Coccidioidomycosis: knowledge, attitudes, and practices among healthcare providers - Arizona, 2007

被引:24
作者
Chen, Sanny [1 ,2 ]
Erhart, Laura M. [2 ]
Anderson, Shoana [2 ]
Komatsu, Ken [2 ]
Park, Benjamin [3 ]
Chiller, Tom [3 ]
Sunenshine, Rebecca [2 ,4 ]
机构
[1] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA
[2] Arizona Dept Hlth Serv, Bur Epidemiol & Dis Control Serv, Phoenix, AZ 85007 USA
[3] Div Foodborne Bacterial & Mycot Dis, Atlanta, GA USA
[4] CDC, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA
关键词
coccidioidomycosis; fungus; KAP survey; community-acquired pneumonia; lung disease; SURVEILLANCE; ANTIBODIES; IMMITIS; TESTS; EIA; USA;
D O I
10.3109/13693786.2010.547995
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Coccidioidomycosis presumably causes < a parts per thousand currency sign 33% of community-acquired pneumonias cases, although < 15% of the patients are tested for coccidioidomycosis. We assessed healthcare providers'' knowledge, attitudes, and practices regarding coccidioidomycosis diagnosis and treatment in Arizona. A survey was mailed to 7,608 eligible healthcare providers licensed by the Arizona medical, osteopathic, and nursing boards in October and December 2007. We used weights to adjust for non-response and multivariate logistic regression models to identify predictors of >= a parts per thousand yen 70% correct regarding knowledge and treatment practices. Of 1,823 (24%) respondents, 53% were physicians, 52% were male, and the mean age was 51 years. Approximately 50% reported confidence in their ability to treat coccidioidomycosis, and 21% correctly answered all four treatment questions. Predictors of >= a parts per thousand yen 70% correct concerning knowledge and treatment practices included always counseling patients after diagnosis (adjusted odds ratio [AOR] == 4.4; 95% confidence interval [CI]: 2.8--7.1); specializing in infectious diseases (AOR == 2.4; 95% CI: 1.0--5.7); and having received coccidioidomycosis continuing medical education (CME) in the last year (AOR == 1.8; 95% CI: 1.2--2.6). These findings demonstrate that coccidioidomycosis CME improves knowledge of disease diagnosis and management, underscoring the need for a comprehensive coccidioidomycosis education campaign for healthcare providers in Arizona.
引用
收藏
页码:649 / 656
页数:8
相关论文
共 24 条
[1]  
Abbas A.K., 2007, CELLULAR MOL IMMUNOL
[2]   The Spectrum and Presentation of Disseminated Coccidioidomycosis [J].
Adam, Rodney D. ;
Elliott, Sean P. ;
Taljanovic, Mihra S. .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (08) :770-777
[3]   Coccidioidomycosis: A Review of Recent Advances [J].
Ampel, Neil M. .
CLINICS IN CHEST MEDICINE, 2009, 30 (02) :241-+
[4]   Coccidioidomycosis in Arizona: Increase in incidence from 1990 to 1995 [J].
Ampel, NM ;
Mosley, DG ;
England, B ;
Vertz, PD ;
Komatsu, K ;
Hajjeh, RA .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1528-1530
[5]  
*AR DEP HLTH SERV, VALL FEV ANN REP 200
[6]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P109
[7]   Testing for coccidioidomycosis among patients with community-acquired pneumonia [J].
Chang, Douglas C. ;
Anderson, Shoana ;
Wannemuehler, Kathleen ;
Engelthaler, David M. ;
Erhart, Laura ;
Sunenshine, Rebecca H. ;
Burwell, Lauren A. ;
Park, Benjamin J. .
EMERGING INFECTIOUS DISEASES, 2008, 14 (07) :1053-1059
[8]   Coccidioidomycosis [J].
Chiller, TM ;
Galgiani, JN ;
Stevens, DA .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (01) :41-+
[9]   Practice guidelines for the treatment of coccidioidomycosis [J].
Galgiani, JN ;
Ampel, NM ;
Catanzaro, A ;
Johnson, RH ;
Stevens, DA ;
Williams, PL .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) :658-661
[10]   Coccidioidomycosis [J].
Galgiani, JN ;
Ampel, NM ;
Blair, JE ;
Catanzaro, A ;
Johnson, RH ;
Stevens, DA ;
Williams, PL .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) :1217-1223